Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

322 ARTÍCULOS , VIENDO DEL 226 AL 240

Overview of Chinese research on senile dementia in mainland China

Song Y, Wang J.

Ageing Res Rev. 2010 Nov;9 Suppl 1:S6-12. doi: 10.1016/j.arr.2010.08.007. Epub 2010 Sep 8.

ACS chemical neuroscience molecule spotlight on dimebon

Hopkins CR.

ACS Chem Neurosci. 2010 Sep 15;1(9):587-8. doi: 10.1021/cn1000588.

Clinical progression of moderate-to-severe Alzheimer's disease and caregiver burden: a 12-month multicenter prospective observational study

Agüera-Ortiz L, Frank-García A, Gil P, Moreno A; 5E Study Group.

Int Psychogeriatr. 2010 Dec;22(8):1265-79. doi: 10.1017/S104161021000150X. Epub 2010 Sep 20.

[Workplace health promotion through human resources development part I: development and evaluation of qualification programme for prevention of psychic stresses]

Zimber A, Gregersen S, Kuhnert S, Nienhaus A.

Gesundheitswesen. 2010 Apr;72(4):209-15. doi: 10.1055/s-0029-1214403. Epub 2009 Jun 16.

The ADAS-cog and clinically meaningful change in the VISTA clinical trial of galantamine for Alzheimer's disease

Rockwood K, Fay S, Gorman M.

Int J Geriatr Psychiatry. 2010 Feb;25(2):191-201. doi: 10.1002/gps.2319.

Effects of insulinic therapy on cognitive impairment in patients with Alzheimer disease and diabetes mellitus type-2

Plastino M, Fava A, Pirritano D, Cotronei P, Sacco N, Sperlì T, Spanò A, Gallo D, Mungari P, Consoli D, Bosco D.

J Neurol Sci. 2010 Jan 15;288(1-2):112-6. doi: 10.1016/j.jns.2009.09.022.

Depression in Alzheimer's disease. Pathophysiology, diagnosis, and treatment

Modrego PJ.

J Alzheimers Dis. 2010;21(4):1077-87. doi: 10.3233/jad-2010-100153.

Double-blind, controlled phase II study of a 5-HT6 receptor antagonist, SB-742457, in Alzheimer's disease

Maher-Edwards G, Zvartau-Hind M, Hunter AJ, Gold M, Hopton G, Jacobs G, Davy M, Williams P.

Curr Alzheimer Res. 2010 Aug;7(5):374-85. doi: 10.2174/156720510791383831.

An update on clinical proteomics in Alzheimer's research

Korolainen MA, Nyman TA, Aittokallio T, Pirttilä T.

J Neurochem. 2010 Mar;112(6):1386-414. doi: 10.1111/j.1471-4159.2009.06558.x. Epub 2009 Dec 24.

Management of behavioral problems in Alzheimer's disease

Gauthier S, Cummings J, Ballard C, Brodaty H, Grossberg G, Robert P, Lyketsos C.

Int Psychogeriatr. 2010 May;22(3):346-72. doi: 10.1017/S1041610209991505. Epub 2010 Jan 25.

Dissecting dementia, depression, and drug effects in older adults

Sherrod RA, Collins A, Wynn S, Gragg M.

J Psychosoc Nurs Ment Health Serv. 2010 Jan;48(1):39-47. doi: 10.3928/02793695-20091204-01.

Galantamine for Alzheimer's disease

Prvulovic D, Hampel H, Pantel J.

Expert Opin Drug Metab Toxicol. 2010 Mar;6(3):345-54. doi: 10.1517/17425251003592137.

A view from the USA on the Alzheimer's disease international position paper

Rubenstein LZ.

J Nutr Health Aging. 2010 Feb;14(2):104. doi: 10.1007/s12603-010-0019-8.

The primary care physician and Alzheimer's disease: an international position paper

Villars H, Oustric S, Andrieu S, Baeyens JP, Bernabei R, Brodaty H, Brummel-Smith K, Celafu C, Chappell N, Fitten J, Frisoni G, Froelich L, Guerin O, Gold G, Holmerova I, Iliffe S, Lukas A, Melis R, Morley JE, Nies H, Nourhashemi F, Petermans J, Ribera Casado J, Rubenstein L, Salva A, Sieber C, Sinclair A, Schindler R, Stephan E, Wong RY, Vellas B.

J Nutr Health Aging. 2010 Feb;14(2):110-20. doi: 10.1007/s12603-010-0022-0.

Follow-up for Alzheimer patients: European Alzheimer Disease Consortium position paper

Nourhashémi F, Olde Rikkert MG, Burns A, Winblad B, Frisoni GB, Fitten J, Vellas B.

J Nutr Health Aging. 2010 Feb;14(2):121-30. doi: 10.1007/s12603-010-0023-z.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias